These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 341799)

  • 1. [Biological properties of L-asparaginase preparations from E. coli in cell cultures].
    Kondrat'eva NA; Dobrynin IaV; Merkulov MF
    Antibiotiki; 1978 Jan; 23(1):43-5. PubMed ID: 341799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological properties of an asparaginase-glutaminase preparation from Pseudomonas fluorescens in cell cultures].
    Kondrat'eva NA; Dobrynin IaV; Merkulov MF
    Antibiotiki; 1978 Feb; 23(2):122-5. PubMed ID: 415658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular test system for studying the biological properties of preparations with L-asparaginase activity].
    Kondrat'eva NA; Dobrynin IaV; Merkulov MF
    Antibiotiki; 1977 Nov; 22(11):994-8. PubMed ID: 596848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG; Sokolov AB; Navashin SM
    Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physicochemical properties and antileukemic activity of crystalline L-asparaginase from Escherichia coli].
    Nikolaev AIa; Kozlov EA; Sokolov NN; Kondrat'eva NA; Dobrynin IaV
    Vopr Med Khim; 1974 May; 20(3):272-6. PubMed ID: 4599797
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of E. coli-L-asparaginase on the nucleic acid metabolism of lymphatic bovine leukemia cells].
    Seeber S; Warnecke P; Straub OC
    Arzneimittelforschung; 1969 Oct; 19(10):1745-8. PubMed ID: 4902492
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
    Boos J
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity].
    Sokolov NN; Zanin VA; Aleksandrova SS
    Vopr Med Khim; 2000; 46(6):531-48. PubMed ID: 11234278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J; Cole DE; Holcenberg JS; Poplack DG
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia.
    Oza VP; Parmar PP; Kumar S; Subramanian RB
    Appl Biochem Biotechnol; 2010 Mar; 160(6):1833-40. PubMed ID: 19448978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biosynthesis of L-asparaginase-2 by cultures of Bacillus polymyxa var. Ross].
    Nefelova MV; Ignatov SG; Chigalenchik AG; Vinogradov BD; Egorov NS
    Prikl Biokhim Mikrobiol; 1978; 14(4):510-4. PubMed ID: 724659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of different pH values on the activity and quaternary structure of asparaginase in Escherichia coli extracts].
    Maksimov VI; Molodova GA; Bespalova TI; Denisov VM
    Prikl Biokhim Mikrobiol; 1975; 11(4):539-45. PubMed ID: 1737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the clinical effectiveness of 3 preparations of E. coli L-asparaginase].
    Kondrat'eva NA
    Antibiotiki; 1984 Jul; 29(7):527-31. PubMed ID: 6385831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effect of hypoglycemia and L-asparaginase upon transplantable hepatomas of varying growth rates.
    Becker FF; Klein KM
    Cancer Res; 1972 Oct; 32(10):2082-4. PubMed ID: 4343006
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural and functional insights into Erwinia carotovora L-asparaginase.
    Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
    FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of asparaginase from Escherichia coli at different stages of purification].
    Maksimov VI; Molodova GA; Uvarkina TP; Danilova TI
    Prikl Biokhim Mikrobiol; 1976; 12(4):552-6. PubMed ID: 800257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nutritional requirement of cancer cells: inhibition of the growth of cancer cells by L-asparaginase].
    Honjo T; Hayaishi O
    Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):515-23. PubMed ID: 4913828
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ extraction of intracellular L-asparaginase using thermoseparating aqueous two-phase systems.
    Zhu JH; Yan XL; Chen HJ; Wang ZH
    J Chromatogr A; 2007 Apr; 1147(1):127-34. PubMed ID: 17328902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
    Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.